Femring and vaginal haemorrhage Patient Reports February 10, 2012

Femring Side Effects Report #5199484-3
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Female patient, 56 years of age, weighting 145.1 lb, was diagnosed with vulvovaginal dryness and was treated with Femring. After drug was administered, patient experienced the following side effects: uterine polyp, vaginal haemorrhage, vulvovaginal mycotic infection. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with PREMPRO, VITAMINS, FOSAMAX. Patient recovered.

Femring Side Effects Report #5347896-7
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2006. Female patient, 43 years of age, weighting 136.9 lb, was diagnosed with urinary tract infection  and was treated with Femring. After drug was administered, patient experienced the following side effects: amenorrhoea, headache , panic attack, sleep disorder , vaginal haemorrhage. Femring dosage: unknown. Patient recovered.

Femring Side Effects Report #4840389-2
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2005. Female patient, 43 years of age, weighting 200.0 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: vaginal haemorrhage. Femring dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with TARKA, CLONIDINE, METHADONE, PERCOCET, XANAX. Patient recovered.

Femring Side Effects Report #5347891-8
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2006. Female patient, 54 years of age, weighting 130.1 lb, was diagnosed with hot flush, night sweats, vulvovaginal dryness and was treated with Femring. After drug was administered, patient experienced the following side effects: uterine cancer , uterine haemorrhage, uterine leiomyoma, vaginal haemorrhage. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.


Femring Side Effects Report #4860544-5
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2005. Female patient, 54 years of age, weighting 177.9 lb, was diagnosed with artificial menopause and was treated with Femring. After drug was administered, patient experienced the following side effects: medical device complication, vaginal haemorrhage. Femring dosage: 0.05 MG, QD, VAGINAL. Patient recovered.